CH551412A - Verfahren zur herstellung neuer n-phenylindolin-derivate. - Google Patents

Verfahren zur herstellung neuer n-phenylindolin-derivate.

Info

Publication number
CH551412A
CH551412A CH1883569A CH1883569A CH551412A CH 551412 A CH551412 A CH 551412A CH 1883569 A CH1883569 A CH 1883569A CH 1883569 A CH1883569 A CH 1883569A CH 551412 A CH551412 A CH 551412A
Authority
CH
Switzerland
Prior art keywords
phenylindoline
derivatives
preparation
new
phenylindoline derivatives
Prior art date
Application number
CH1883569A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH551412A publication Critical patent/CH551412A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1883569A 1968-12-18 1969-12-18 Verfahren zur herstellung neuer n-phenylindolin-derivate. CH551412A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB60083/68A GB1237008A (en) 1968-12-18 1968-12-18 Novel indoline derivatives

Publications (1)

Publication Number Publication Date
CH551412A true CH551412A (de) 1974-07-15

Family

ID=10484978

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1883569A CH551412A (de) 1968-12-18 1969-12-18 Verfahren zur herstellung neuer n-phenylindolin-derivate.
CH1290273A CH551411A (de) 1968-12-18 1969-12-18 Verfahren zur herstellung neuer n-phenylindolin-derivate.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1290273A CH551411A (de) 1968-12-18 1969-12-18 Verfahren zur herstellung neuer n-phenylindolin-derivate.

Country Status (10)

Country Link
US (2) US3644403A (de)
JP (2) JPS5011915B1 (de)
BE (1) BE743250A (de)
BR (1) BR6915242D0 (de)
CH (2) CH551412A (de)
DE (1) DE1963182C2 (de)
ES (1) ES374644A2 (de)
FR (1) FR2026492B2 (de)
GB (1) GB1237008A (de)
SE (1) SE360862B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882236A (en) * 1973-12-26 1975-05-06 Lilly Co Eli Pharmaceutical compositions containing substituted 2-oxo-indolines and the use thereof to treat anxiety and tension
US4080330A (en) * 1975-06-23 1978-03-21 Delmar Chemicals Limited Phenylindolines and process for their production
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
FR2420536A1 (fr) * 1978-03-22 1979-10-19 Roussel Uclaf Nouveaux derives de 1,3-dihydro 3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl)2-hydroxyethyl/piperidin-4-yl/2h-indol-2-one, procede pour leur preparation et application comme medicaments
JPS556986U (de) * 1978-06-30 1980-01-17
DE2933636A1 (de) * 1978-08-30 1980-03-20 Sandoz Ag Neue n-phenylindolinderivate, ihre herstellung und pharmazeutische praeparate, welche diese verbindungen enthalten
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4977178A (en) * 1982-09-20 1990-12-11 Pfizer Inc. Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4694017A (en) * 1983-05-19 1987-09-15 Otsuka Pharmaceutical Co., Ltd. 2-amido 3(oxindol-3-yl)propionic acids having antiulcer activity
US5229413A (en) * 1989-05-05 1993-07-20 G. D. Searle & Co. Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
DK139593D0 (da) * 1993-12-16 1993-12-16 Lundbeck & Co As H Compounds
WO1996004274A1 (en) * 1994-08-02 1996-02-15 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives
WO2000076981A1 (en) * 1999-06-15 2000-12-21 Neurogen Corporation Piperidinyl and piperazinyl substituted benzofused lactams

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184466A (en) * 1965-05-18 Beta amino butyrylxnbqlines
US2759935A (en) * 1953-02-18 1956-08-21 Bristol Lab Inc Substituted 3-phenyloxindoles
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
US3468907A (en) * 1967-04-10 1969-09-23 Schering Corp Glyceryl esters of alpha-(1-aroyl-3-indolyl)alkanoic acids

Also Published As

Publication number Publication date
FR2026492A2 (de) 1970-09-18
BE743250A (de) 1970-06-17
US3720771A (en) 1973-03-13
FR2026492B2 (de) 1974-02-01
JPS5218702B1 (de) 1977-05-24
CH551411A (de) 1974-07-15
ES374644A2 (es) 1972-02-16
BR6915242D0 (pt) 1973-02-13
DE1963182A1 (de) 1970-10-15
JPS5011915B1 (de) 1975-05-07
GB1237008A (en) 1971-06-30
SE360862B (de) 1973-10-08
DE1963182C2 (de) 1983-05-19
US3644403A (en) 1972-02-22

Similar Documents

Publication Publication Date Title
CH542232A (de) Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate
CH535244A (de) Verfahren zur Herstellung neuer 5-Phenyltetrazol-Derivate
AT309696B (de) Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate
CH551411A (de) Verfahren zur herstellung neuer n-phenylindolin-derivate.
AT306714B (de) Verfahren zur Herstellung neuer Nitroimidazolderivate
AT289131B (de) Verfahren zur Herstellung neuer 2-Alkylthio-4,6-diamino-s-triazine
AT289776B (de) Verfahren zur Herstellung neuer 1-Carbamoyl-3-aroylpyrrolidine
CH516508A (de) Verfahren zur Herstellung neuer substituierter Hydroxyphenylalkylamine
AT303000B (de) Verfahren zur Herstellung neuer Triazenderivate
AT301522B (de) Verfahren zur Herstellung neuer substituierter 2-Phenyl-2-hydroxy- oder acyloxy-1,1-dihalogenäthane
AT289132B (de) Verfahren zur Herstellung neuer s-Triazin-Derivate
CH507959A (de) Verfahren zur Herstellung neuer Pyrimidin-Derivate
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
CH520156A (de) Verfahren zur Herstellung neuer Perhydro-5-phenylcyclo-alkapolyen-1,4-oxazepine
CH517103A (de) Verfahren zur Herstellung neuer 5-Aryl-, bzw. Heteroaryl-Benzotetrahydrodiazepin-24-dione
CH496719A (de) Verfahren zur Herstellung neuer Pyrrolopyrimidin-Derivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
AT305253B (de) Verfahren zur Herstellung neuer Diphenoxyacetamide
AT301036B (de) Verfahren zur Herstellung neuer Neriifolin-Derivate
AT287703B (de) Verfahren zur Herstellung neuer Imidazolderivate
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
AT295515B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-pyrazolidine
CH513131A (de) Verfahren zur Herstellung neuer Aminobenzocycloalkylnitrile
CH528513A (de) Verfahren zur Herstellung neuer substituierter Triazenopyrazole
AT294102B (de) Verfahren zur Herstellung neuer Piperazinderivate

Legal Events

Date Code Title Description
PL Patent ceased